Editor's introduction—genetic polymorphisms and clinical heterogeneities

Lambie M. , Chess J. , Donovan K.L. , Kim Y.L. , Do J.Y. , Lee H.B. Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival. J Am Soc Nephrol 2013; 24(12): 2071–80.

Ong A.C. , Devuyst O. , Knebelmann B. , Walz G. ERA-EDTA Working Group for Inherited Kidney Diseases. Autosomal dominant polycystic kidney disease: the changing face of clinical management. Lancet 2015; 385(9981): 1993–2002.

Lobbedez T. , Touam M. , Evans D. , Ryckelynck J.P. , Knebelman B. , Verger C. Peritoneal dialysis in polycystic kidney disease patients. Report from the French peritoneal dialysis registry (RDPLF). Nephrol Dial Transplant 2011; 26(7): 2332–9.

Zoccali C. Pulmonary hypertension in dialysis patients: a prevalent, risky but still uncharacterized disorder. Nephrol Dial Transplant 2012; 27(10): 3674–7.